Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cayson Acquisition Corp

10.20
+0.0000
Volume:- -
Turnover:1.32K
Market Cap:74.75M
PE:- -
High:10.20
Open:10.20
Low:10.20
Close:10.20
Loading ...

Company Profile

Company Name:
Cayson Acquisition Corp
Exchange:
NASDAQ
Establishment Date:
2024
Employees:
- -
Office Location:
420 Lexington Avenue,Suite 2446,New York,New York,United States
Zip Code:
10170
Fax:
- -
Introduction:
Capnia, Inc. develops and commercializes neonatology devices, diagnostics, and therapeutics platform based on its proprietary technology for precision metering of gas flow primarily in the United States. The company offers CoSense, an end-tidal carbon monoxide monitor, for the diagnosis of excessive hemolysis in neonates with jaundice, a condition that causes long-term developmental disability due to the degradation of red blood cells. It also develops Serenz, a therapeutic product candidate that has completed Phase II clinical trials for the treatment of symptoms related to allergic rhinitis. In addition, the company provides NeoPip T-piece resuscitator and related consumables, which delivers consistent pre-set inspiratory pressure and positive end-expiratory pressures; temperature probes; scales; surgical tables; and patient surfaces for inpatient and ambulatory neonatal markets. Capnia, Inc. was founded in 1999 and is headquartered in Redwood City, California.

Directors

Name
Position
Yawei Cao
Chairman of the Board and Chief Executive Officer
Annie Liang Zhou
Independent Director
Raymond Xia
Independent Director
Yue Zhuge
Independent Director

Shareholders

Name
Position
Yawei Cao
Chairman of the Board and Chief Executive Officer
Dahe Zhang
Chief Financial Officer